Skip to content

Study on the intervention and mechanism of auricular magnetic bead pressing in critically ill mechanically ventilated patients receiving sedation and analgesia: A pilot randomized controlled trial

Study on the intervention and mechanism of auricular magnetic bead pressing in critically ill mechanically ventilated patients receiving sedation and analgesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073803
Enrollment
Unknown
Registered
2023-07-21
Start date
2018-11-13
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sedation and analgesia in patients with mechanical ventilation

Interventions

Control group:All the patients received fentanyl in a dose of 0.5-2.0 µg/kg for analgesia induction and a dose of 0.3-1.07 µg/kg/h for continuous infusion. On this basis, the participants were treated
dexmedetomidine, maintained by continuous pumping at 0.2-0.7 µg/kg/h
and propofol, which was induced by intravenous infusion of 1.0-3.0 mg/kg within 5 min, and followed by continuous infusion of 0.5-4.0 mg/kg/h.
Treatment group:For the treatment group, auricular magnetic bead pressing was added as an adjuvant therapy on the basis of the control group

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients admitted to ICU and EICU, aged = 18 years old, regardless of gender, with an estimated hospital stay of more than 24 hours; Patients who need to receive mechanical ventilation treatment during hospitalization due to their condition, with an estimated mechanical ventilation time of = 24 hours and need continuous analgesia and sedation; In order to ensure the stability of the baseline when patients with pain and restlessness are enrolled in the group, it is required that the CPOT score = 3 and SAS score = 5 when no sedative and analgesic drugs are given before hospitalization; The patient or family member has signed an informed consent form.

Exclusion criteria

Exclusion criteria: Those who are in a coma state before treatment and cannot undergo analgesic and sedative assessment; Infectious diseases, such as hepatitis B and active pulmonary tuberculosis; Researchers believe that there is poor compliance or inability to cooperate; Ear skin damage; Individuals who are allergic to adhesive tape.

Design outcomes

Primary

MeasureTime frame
CPOT score;SAS score;

Secondary

MeasureTime frame
Adrenocorticotropic hormone;Cortisol;Melatonin;Methionine-enkephalin;

Countries

China

Contacts

Public ContactLi Jie

Xiyuan Hospital, CACMS

lijie0920@hotmail.com+86 158 1026 9249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026